Primary cutaneous mucormycosis in an immunocompetent host: report of a case.
Cutaneous mucormycosis is an uncommon disease and it usually affects immunocompromised, diabetic, and trauma patients with contaminated wounds or patients with underlying malignancies. It is very rare to find this disease in immunocompetent, nondiabetic patients. We herein report a case of primary cutaneous mucormycosis in an immunocompetent and nondiabetic patient. Our patient was a 50-year-old veterinary doctor. He was diagnosed to have cutaneous mucormycosis of the anterior abdominal wall, and was treated with multiple debridements of the wound and intravenous amphotericin B therapy. He received a total of 1000 mg of amphotericin B. A high index of clinical suspicion and early institution of therapy in the form of surgical debridements and antifungal drugs are required to achieve a successful outcome.
Kumar
Arvind
A
Department of Surgical Disciplines, All India Institute of Medical Sciences, New Dehli, India.
Khilnani
Gopi C
GC
Aggarwal
Sandeep
S
Kumar
Subodh
S
Banerjee
Uma
U
Xess
Immaculata
I
D000666:Amphotericin B / Q000627:therapeutic use; D003646:Debridement; D006801:Humans; D007121:Immunocompetence; D008297:Male; D008875:Middle Aged; D009091:Mucormycosis / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D017192:Skin Diseases, Bacterial / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*
D000666:Amphotericin B